COL1A1

Collagen alpha-1(I) chain · P02452 · COL1A1 on Sugi Atlas →

555 patent compounds predicted against COL1A1, 348 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL15133348 SCHEMBL15133348 0.64 12/20
SCHEMBL14865287 SCHEMBL14865287 0.53 12/20
SCHEMBL28746315 SCHEMBL28746315 0.50 5/20
SCHEMBL27147420 SCHEMBL27147420 0.68 4/20
SCHEMBL26192501 SCHEMBL26192501 0.67 4/20
SCHEMBL27148833 SCHEMBL27148833 0.66 4/20
SCHEMBL27145904 SCHEMBL27145904 0.60 4/20
SCHEMBL29958870 SCHEMBL29958870 0.60 4/20
SCHEMBL26622443 SCHEMBL26622443 0.59 4/20
SCHEMBL25566771 SCHEMBL25566771 0.59 4/20
SCHEMBL29222857 SCHEMBL29222857 0.55 4/20
SCHEMBL30906667 SCHEMBL30906667 0.55 4/20
SCHEMBL29403903 SCHEMBL29403903 0.34 4/20
Palmitine Palmitine (SCHEMBL562120) 0.70 3/20
Palmitine Palmitine (SCHEMBL29350054) 0.70 3/20
Palmitine Palmitine (SCHEMBL29471136) 0.70 3/20
Palmitine Palmitine (SCHEMBL754702) 0.69 3/20
Palmitine Palmitine (SCHEMBL2445279) 0.69 3/20
Palmitine Palmitine (SCHEMBL29376263) 0.69 3/20
Palmitine Palmitine (SCHEMBL29766942) 0.69 3/20

Clinical trials — most relevant to COL1A1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Effect of Dapagliflozin on Renal Outcomes and Bone Mineral Disease in Non-diabetic Chronic Kidney Disease Patients PHASE4COMPLETED
5FU vs 5FU With Viscoelastic Formulation for the Prevention of Scarring Post-trabeculectomy PHASE4COMPLETED
Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta PHASE3ACTIVE_NOT_RECRUITING
Pamidronate to Treat Osteogenesis Imperfecta in Children PHASE3COMPLETED
A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women PHASE3COMPLETED
Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI PHASE2COMPLETED
Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN) PHASE2RECRUITING
Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab PHASE2COMPLETED
Boost to Brittle Bones - Stem Cell Transplantation for Treatment of Brittle Bones PHASE1/PHASE2UNKNOWN
The Benefit of Bermekimab in Patients With Systemic Sclerosis PHASE2COMPLETED
Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers PHASE1UNKNOWN
Telescoping Nail in Osteogenesis Imperfecta nanACTIVE_NOT_RECRUITING
Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital nanNOT_YET_RECRUITING
Resistance Exercise and Hydrolyzed Collagen Supplementation nanCOMPLETED
Clear Aligners for the Treatment of Dental Malocclusion in OI nanACTIVE_NOT_RECRUITING
Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment nanNOT_YET_RECRUITING
Acute Resistance Exercise and Hydrolyzed Collagen Supplementation nanCOMPLETED
Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study nanCOMPLETED
Osteogenesis Imperfecta Blood Pressure Study nanCOMPLETED
Effect of Thiazolidinediones on Human Bone nanCOMPLETED
Impact of Comorbidities, Some Biomarkers, Micro RNA in Childhood Asthma Phenotypes nanNOT_YET_RECRUITING
Evaluation of High-Purity Type I Collagen Biologic Wrap to Improve Function After Extensor Tendon Repair of the Hand nanCOMPLETED
Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation nanCOMPLETED
Effects of a Dietary Supplement on Collagen Production and Evaluation of Its Regenerative and Anti-Ageing Propertiess nanCOMPLETED
Re-evaluation of Some Old Rheumatoid Arthritis Therapy: A Randomized Controlled Trial nanCOMPLETED
Fibroblast Line Evaluation for COL5A eXpression and Thoracic Aortic Aneurysms: in Vitro Characterization of Cutaneous Fibroblasts in Adult Patients nanNOT_YET_RECRUITING
Impact of the Source and Food Matrices on the Bioavailability of Peptan® (Collagen Peptides) in Healthy Subjects nanCOMPLETED
Microneedling With Topical Preparations in the Treatment of Atrophic Post-acne Scars nanUNKNOWN
Effects of Epicatechin-rich Cocoa on Collagen Synthesis nanCOMPLETED
Impact of Milk and Yogurt Supplementation on Bone Health, Body Composition, and Gut Microbiota in Canadian Young Adults nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a COL1A1 binder may also engage these)

ProteinNameSimilarity
P11087 1.000 P11087 →
Q9XSJ7 1.000 Q9XSJ7 →
C0HLG9 1.000 C0HLG9 →
P02453 1.000 P02453 →
P02457 1.000 P02457 →
C0HLH3 1.000 C0HLH3 →
COL2A1 Collagen alpha-1(II) chain 1.000 landscape →
P05539 0.998 P05539 →
C0HLJ3 0.998 C0HLJ3 →
Q6P4Z2 0.997 Q6P4Z2 →
P28481 0.996 P28481 →
P02459 0.996 P02459 →
C0HLI9 0.995 C0HLI9 →
C0HLI7 0.995 C0HLI7 →
C0HLJ7 0.994 C0HLJ7 →
Q91717 0.994 Q91717 →
Q9YIB4 0.993 Q9YIB4 →
C0HLJ5 0.993 C0HLJ5 →
C0HM93 0.993 C0HM93 →
C0HJP3 0.993 C0HJP3 →
P02454 0.993 P02454 →
P0C2W8 0.993 P0C2W8 →
C0HLI3 0.992 C0HLI3 →
C0HLH9 0.992 C0HLH9 →
C0HLH5 0.991 C0HLH5 →
C0HLI1 0.991 C0HLI1 →
C0HLG7 0.991 C0HLG7 →
C0HJN3 0.990 C0HJN3 →
P02461 0.988 P02461 →
C0HJP7 0.988 C0HJP7 →